NLGN4X and breast cancer: To evaluate the expression and localization of NLGN4X in breast cancer tissues, immunohistochemistry was used to evaluate samples from 60 patients, consisting of adjacent normal tissue (9 patients), breast cancer tissues tumors (40) and respective lymph node metastasis (10).